1
USE OF FRAX® WITHOUT BMD TO ASSESS RISK OF FRACTURE IN AN OUT-PATIENT POPULATION Clifford, G.T., Slattery, C., van der Kamp, S., McKenna, M. Background Fractures place a significant burden on the patient, the hospital and the healthcare system in terms of cost, morbidity, mortality. Each year there are 3000 hospital admissions due to hip fracture (IHFD 2013). Hospital out-patient departments, as major healthcare providers to its local catchment area have an opportunity to be at the forefront of identifying risk of fracture among its patients. FRAX® has been recommended by WHO for use in identifying patients at risk of fracture and has been validated in a number of populations and healthcare settings. Correspondence: [email protected] 17 22 7 0 5 10 15 20 25 Low Intermediate High Risk of Fracture Low Intermediate High 2 5 5 12 9 7 9 8 44 39 40 32 37 38 37 38 0 10 20 30 40 50 Osteoporosis Risk Factors Yes No Don't Know Nearly 60% of patients warranted investigation and/or treatment for osteoporosis. Aim To identify the risk of fracture in an out- patient population and to determine who would benefit from osteoporosis treatment. Methodology All patients over 50 years were considered for inclusion for this cross-sectional study. A convenience sample of 50 patients was selected from an IV Therapies Suite. FRAX® without BMD using clinical risk factors, age and BMI was used to determine risk of fracture. Data collection included: age, body mass index, current bone protection medications, previous fragility fractures, parental history of hip fracture, current glucocorticoid use, current smoker and current alcohol use. Descriptive statistics were used. Results Of the 50 participants, there were 31 males, the median age was 64 years and the median BMI was 27 kg/m 2 . Nineteen patients were on Vitamin D or calcium supplements. No patients were on bone protection despite 5 patients with a prior fragility fracture. Conclusion This was an younger, predominately male population in the overweight BMI category. Patients require a comprehensive assessment of both risk of fracture and risk of falling to prevent a harmful fall. The risk factors for both fracture and falls are not interchangeable. Identifying risk of fracture, and subsequent investigation and/or treatment could significantly reduce the risk of fracture and thereby, morbidity, mortality and cost. 14 20 5 0 1 2 0 5 10 15 20 25 Low Intermediate High Falls v Risk of Fracture 2 1 0

Use of FRAX without BMD to Assess Risk of Fracture in Out-Patient Population

Embed Size (px)

Citation preview

USE OF FRAX® WITHOUT BMD TO ASSESS

RISK OF FRACTURE IN AN OUT-PATIENT POPULATION

Clifford, G.T., Slattery, C., van der Kamp, S., McKenna, M.

Background

• Fractures place a significant burden on thepatient, the hospital and the healthcaresystem in terms of cost, morbidity,mortality. Each year there are 3000 hospitaladmissions due to hip fracture (IHFD2013). Hospital out-patient departments, asmajor healthcare providers to its localcatchment area have an opportunity to beat the forefront of identifying risk of fractureamong its patients.

• FRAX® has been recommended by WHOfor use in identifying patients at risk offracture and has been validated in anumber of populations and healthcaresettings.

Correspondence: [email protected]

17

22

7

0

5

10

15

20

25

Low Intermediate High

Risk of Fracture

LowIntermediateHigh

2 5 512 9 7 9 8

44 39 4032 37 38 37 38

0

10

20

30

40

50

Osteoporosis Risk Factors

YesNoDon't Know

• Nearly 60% of patients warrantedinvestigation and/or treatment forosteoporosis.

Aim

• To identify the risk of fracture in an out-patient population and to determine whowould benefit from osteoporosis treatment.

Methodology

• All patients over 50 years were consideredfor inclusion for this cross-sectional study.

• A convenience sample of 50 patients wasselected from an IV Therapies Suite.

• FRAX® without BMD using clinical riskfactors, age and BMI was used todetermine risk of fracture.

• Data collection included: age, body massindex, current bone protection medications,previous fragility fractures, parental historyof hip fracture, current glucocorticoid use,current smoker and current alcohol use.

• Descriptive statistics were used.

Results

• Of the 50 participants, there were 31males, the median age was 64 years andthe median BMI was 27 kg/m2. Nineteenpatients were on Vitamin D or calciumsupplements. No patients were on boneprotection despite 5 patients with a priorfragility fracture.

Conclusion

• This was an younger, predominately malepopulation in the overweight BMI category.

• Patients require a comprehensiveassessment of both risk of fracture and riskof falling to prevent a harmful fall. The riskfactors for both fracture and falls are notinterchangeable.

• Identifying risk of fracture, and subsequentinvestigation and/or treatment couldsignificantly reduce the risk of fracture andthereby, morbidity, mortality and cost.

1420

5

0

1

2

0

5

10

15

20

25

Low Intermediate High

Falls v Risk of Fracture

≥210